Article

Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, Massachusetts 02139, USA.
Journal of Virology (Impact Factor: 4.65). 08/2009; 83(19):9694-708. DOI: 10.1128/JVI.00925-09
Source: PubMed

ABSTRACT Human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein modifications over the course of infection have been associated with coreceptor switching and antibody neutralization resistance, but the effect of the changes on replication and host cell receptor usage remains unclear. To examine this question, unique early- and chronic-stage infection envelope V1-to V5 (V1-V5) segments from eight HIV-1 subtype A-infected subjects were incorporated into an isogenic background to construct replication-competent recombinant viruses. In all subjects, viruses with chronic-infection V1-V5 segments showed greater replication capacity than those with early-infection V1-V5 domains in cell lines with high levels of both the CD4 and the CCR5 receptors. Viruses with chronic-infection V1-V5s demonstrated a significantly increased ability to replicate in cells with low CCR5 receptor levels and greater resistance to CCR5 receptor and fusion inhibitors compared to those with early-infection V1-V5 segments. These properties were associated with sequence changes in the envelope V1-V3 segments. Viruses with the envelope segments from the two infection time points showed no significant difference in their ability to infect cells with low CD4 receptor densities, in their sensitivity to soluble CD4, or in their replication capacity in monocyte-derived macrophages. Our results suggest that envelope changes, primarily in the V1-V3 domains, increase both the ability to use the CCR5 receptor and fusion kinetics. Thus, envelope modifications over time within a host potentially enhance replication capacity.

Download full-text

Full-text

Available from: Anupa Kamat, Apr 03, 2014
0 Followers
 · 
80 Views
  • Source
    • "VRC01, PGT121, and 10E8 antibodies were generated by the transfection of 293F cells with immunoglobulin heavy and light chain plasmids containing the appropriate variable loop domains as described previously (Huang et al., 2012; Sagar et al., 2012; Walker et al., 2011; Wu et al., 2010). Infection of TZM-bl cells in the absence and presence of twofold serial dilution of the antibody was used to estimate the 50% inhibitory concentration (IC 50 ) as previously described (Etemad et al., 2009). All reported IC 50 s are mean estimates from a minimum of two independent assays. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent studies suggest that single genome amplification (SGA) as compared to standard bulk PCR and virus stocks from 293 T transfection versus short term passage in peripheral blood mononuclear cells (PBMC) yield a less biased representation of HIV-1 envelope characteristics. In 9 different subjects, genetic diversity, divergence, and population structure was not significantly different among SGA or bulk PCR amplified envelope V1-V3 segments. In these subjects, 293 T transfection derived virus stocks with SGA or bulk PCR amplified envelopes had similar infectivity, replication kinetics, co-receptor usage, and neutralization susceptibility. While PBMC passage as compared to the 293 T derived virus stocks had similar co-receptor usage, PBMC viruses were less neutralization susceptible to some specific antibodies. Our results suggest that the method of envelope sequence amplification, either SGA or bulk PCR, does not have a significant impact on the genotypic and phenotypic properties of the virus envelope quasispecies.
    Journal of Virological Methods 02/2015; 214. DOI:10.1016/j.jviromet.2015.01.006 · 1.88 Impact Factor
  • Source
    • "Reported data tended to suggest different genetic evolutions between R5 viruses remaining CCR5-using with the progression of the disease and those undergoing a switch [Fernandez et al., 2006; Mild et al., 2010]. The viruses remaining R5 had improved CCR5- use, infecting cells expressing low level of CCR5, and were less well inhibited by anti-CCR5 compounds [Olivieri et al., 2007; Repits et al., 2008; Etemad et al., 2009]. On the contrary, R5 viruses switching to X4 had decreased CCR5 affinity and needed high expression level of CCR5 to enter cells, which contributed to their better susceptibility to CCR5 inhibitors [Pastore et al., 2007; Coetzer et al., 2008; Loftin et al., 2010]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Concordant and discordant genotypic predictions of HIV-1 co-receptor tropism were analyzed. V3 region was sequenced from plasma samples of patients screened for R5 tropism by the Trofile® assay, before CCR5 antagonist prescription. Ten tools including geno2pheno, PSSM, an "11/25" and "net charge" rule, and other published algorithms were used. Patients were grouped according to concordance or discordance between tools and Trofile® result. Trofile® tropism reports from 50 patient samples were R5 in 38 and Dual/Mixed (DM) in 12. Prediction with the genotypic tools were concordant for 23 R5 samples, and discordant for the 15 other ones. From Trofile® DM strains were concordant in 6 and discordant in 6. V3 sequences were not clearly distinct between R5 and DM strains, except a greater diversity in the later. Discordances were found with any tool or combination of them, so that no one can be proposed as better than the others. Predictive values of each algorithm were similar and rather good (efficacy ranged from 74% to 84%), but the rate of non-confirmed prediction is greater when compelling the results of all tools with each individual sample. The mean of quantitative values obtained with one tool when another tool give the opposite prediction were different from those obtained when all tools agree with that prediction. The two discordant groups were often not distinguishable from each other. These results suggest that viruses giving discordant prediction with bioinformatic tools could be functionally distinct and/or in a different evolutionary state compared to those with concordant prediction.
    Journal of Medical Virology 03/2012; 84(3):402-13. DOI:10.1002/jmv.23209 · 2.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Autologous HIV-1-specific neutralizing antibodies (NAbs) seem unable to inhibit viral replication as they rapidly select for neutralization escape variants. However, NAbs could potentially contribute indirectly to the control of HIV-1 if changes in the viral envelope coinciding with NAb escape would impair viral replication fitness. Here we analyzed the replication kinetics of HIV-1 isolated over the course of infection from five typical progressors, three of whom developed strong autologous neutralizing humoral immunity. Viral replication rate did not correlate with viral sensitivity to autologous serum neutralization or with envelope length or number of potential N-linked glycosylation sites in gp120, suggesting that the flexibility of the viral envelope allows escape from NAbs without the loss of viral fitness. Interestingly, the appearance of rapidly replicating viruses late in infection correlated with lower CD4(+) T-cell counts, suggesting that this viral characteristic may be positively selected when the availability of target cells becomes limiting.
    Virology 11/2009; 397(1):224-30. DOI:10.1016/j.virol.2009.11.009 · 3.28 Impact Factor
Show more